272 related articles for article (PubMed ID: 22990804)
1. Vaccination using radiation- or genetically attenuated live sporozoites.
Vaughan AM; Kappe SH
Methods Mol Biol; 2013; 923():549-66. PubMed ID: 22990804
[TBL] [Abstract][Full Text] [Related]
2. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
3. Vaccination using normal live sporozoites under drug treatment.
Rénia L; Grüner AC; Mauduit M; Snounou G
Methods Mol Biol; 2013; 923():567-76. PubMed ID: 22990805
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
Friesen J; Matuschewski K
Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
[TBL] [Abstract][Full Text] [Related]
5. Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization.
Nganou-Makamdop K; Ploemen I; Behet M; Van Gemert GJ; Hermsen C; Roestenberg M; Sauerwein RW
Parasite Immunol; 2012 Dec; 34(12):562-9. PubMed ID: 23171040
[TBL] [Abstract][Full Text] [Related]
6. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
Mueller AK; Labaied M; Kappe SH; Matuschewski K
Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity against malaria liver stage after vaccination with live parasites.
Rénia L
Parasite; 2008 Sep; 15(3):379-83. PubMed ID: 18814710
[TBL] [Abstract][Full Text] [Related]
8. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates.
Annoura T; Ploemen IH; van Schaijk BC; Sajid M; Vos MW; van Gemert GJ; Chevalley-Maurel S; Franke-Fayard BM; Hermsen CC; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM
Vaccine; 2012 Mar; 30(16):2662-70. PubMed ID: 22342550
[TBL] [Abstract][Full Text] [Related]
9. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
[TBL] [Abstract][Full Text] [Related]
10. The intradermal route for inoculation of sporozoites of rodent malaria parasites for immunological studies.
Inoue M; Culleton RL
Parasite Immunol; 2011 Feb; 33(2):137-42. PubMed ID: 21226727
[TBL] [Abstract][Full Text] [Related]
11. The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine.
Chattopadhyay R; Conteh S; Li M; James ER; Epstein JE; Hoffman SL
Vaccine; 2009 Jun; 27(27):3675-80. PubMed ID: 19071177
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of protective immunity induced by irradiation-attenuated sporozoites and its implication for pre-erythrocytic malaria vaccine research].
Xu WY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Feb; 27(1):70-4. PubMed ID: 19459506
[TBL] [Abstract][Full Text] [Related]
13. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.
Good MF
Trends Immunol; 2005 Jun; 26(6):295-7. PubMed ID: 15922944
[TBL] [Abstract][Full Text] [Related]
14. Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine.
Kreutzfeld O; Müller K; Matuschewski K
Front Cell Infect Microbiol; 2017; 7():198. PubMed ID: 28620583
[TBL] [Abstract][Full Text] [Related]
15. Genetic engineering of attenuated malaria parasites for vaccination.
Khan SM; Janse CJ; Kappe SH; Mikolajczak SA
Curr Opin Biotechnol; 2012 Dec; 23(6):908-16. PubMed ID: 22560204
[TBL] [Abstract][Full Text] [Related]
16. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.
Labaied M; Harupa A; Dumpit RF; Coppens I; Mikolajczak SA; Kappe SH
Infect Immun; 2007 Aug; 75(8):3758-68. PubMed ID: 17517871
[TBL] [Abstract][Full Text] [Related]
18. A genetically attenuated parasite vaccine does not require liver stage persistence to elicit sterile protective immunity against sporozoite-induced malaria in mice.
Mikolajczak SA; Vaughan AM; Soliman JM; Kappe SH
J Infect Dis; 2010 Apr; 201(8):1270-1; author reply 1271-2. PubMed ID: 20225958
[No Abstract] [Full Text] [Related]
19. Mosquito production mooted as fast track to malaria vaccine.
Butler D
Nature; 2003 Oct; 425(6957):437. PubMed ID: 14523404
[No Abstract] [Full Text] [Related]
20. Protective Efficacy Induced by Genetically Attenuated Mid-to-Late Liver-Stage Arresting Plasmodium berghei Δmrp2 Parasites.
van der Velden M; Rijpma SR; Verweij V; van Gemert GJ; Chevalley-Maurel S; van de Vegte-Bolmer M; Franke-Fayard BM; Russel FG; Janse CJ; Sauerwein RW; Koenderink JB
Am J Trop Med Hyg; 2016 Aug; 95(2):378-82. PubMed ID: 27296385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
